These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31222149)

  • 1. A MiSeq-HyDRA platform for enhanced HIV drug resistance genotyping and surveillance.
    Taylor T; Lee ER; Nykoluk M; Enns E; Liang B; Capina R; Gauthier MK; Domselaar GV; Sandstrom P; Brooks J; Ji H
    Sci Rep; 2019 Jun; 9(1):8970. PubMed ID: 31222149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External Quality Assessment for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Unique Requirements and Challenges.
    Lee ER; Gao F; Sandstrom P; Ji H
    Viruses; 2020 May; 12(5):. PubMed ID: 32429382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Application of Performance Assessment Criteria for Next-Generation Sequencing-Based HIV Drug Resistance Assays.
    Becker MG; Liang D; Cooper B; Le Y; Taylor T; Lee ER; Wu S; Sandstrom P; Ji H
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32532083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Vela Diagnostics HIV-1 genotyping assay on an automated next generation sequencing platform.
    May S; Adamska E; Tang J
    J Clin Virol; 2020 Jun; 127():104376. PubMed ID: 32344322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 genotypic resistance testing using the Vela automated next-generation sequencing platform.
    Raymond S; Nicot F; Carcenac R; Lefebvre C; Jeanne N; Saune K; Delobel P; Izopet J
    J Antimicrob Chemother; 2018 May; 73(5):1152-1157. PubMed ID: 29444253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next generation sequencing improves detection of drug resistance mutations in infants after PMTCT failure.
    Fisher RG; Smith DM; Murrell B; Slabbert R; Kirby BM; Edson C; Cotton MF; Haubrich RH; Kosakovsky Pond SL; Van Zyl GU
    J Clin Virol; 2015 Jan; 62():48-53. PubMed ID: 25542470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routine drug resistance testing in HIV-1 proviral DNA, using an automated next- generation sequencing assay.
    Alidjinou EK; Coulon P; Hallaert C; Robineau O; Meybeck A; Huleux T; Ajana F; Hober D; Bocket L
    J Clin Virol; 2019 Dec; 121():104207. PubMed ID: 31707202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing.
    Lee ER; Parkin N; Jennings C; Brumme CJ; Enns E; Casadellà M; Howison M; Coetzer M; Avila-Rios S; Capina R; Marinier E; Van Domselaar G; Noguera-Julian M; Kirkby D; Knaggs J; Harrigan R; Quiñones-Mateu M; Paredes R; Kantor R; Sandstrom P; Ji H
    Sci Rep; 2020 Jan; 10(1):1634. PubMed ID: 32005884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation Considerations.
    Ávila-Ríos S; Parkin N; Swanstrom R; Paredes R; Shafer R; Ji H; Kantor R
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32516949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 viraemia and drug resistance amongst female sex workers in Soweto, South Africa: A cross sectional study.
    Coetzee J; Hunt G; Jaffer M; Otwombe K; Scott L; Bongwe A; Ledwaba J; Molema S; Jewkes R; Gray GE
    PLoS One; 2017; 12(12):e0188606. PubMed ID: 29244809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 Drug Resistance Genotyping in Resource Limited Settings: Current and Future Perspectives in Sequencing Technologies.
    Manyana S; Gounder L; Pillay M; Manasa J; Naidoo K; Chimukangara B
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34208165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sanger and Next Generation Sequencing Approaches to Evaluate HIV-1 Virus in Blood Compartments.
    Arias A; López P; Sánchez R; Yamamura Y; Rivera-Amill V
    Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30096879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimethod Longitudinal HIV Drug Resistance Analysis in Antiretroviral-Therapy-Naive Patients.
    Nanfack AJ; Redd AD; Bimela JS; Ncham G; Achem E; Banin AN; Kirkpatrick AR; Porcella SF; Agyingi LA; Meli J; Colizzi V; Nádas A; Gorny MK; Nyambi PN; Quinn TC; Duerr R
    J Clin Microbiol; 2017 Sep; 55(9):2785-2800. PubMed ID: 28659324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next generation sequencing based in-house HIV genotyping method: validation report.
    Ayitewala A; Ssewanyana I; Kiyaga C
    AIDS Res Ther; 2021 Oct; 18(1):64. PubMed ID: 34600538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited Marginal Utility of Deep Sequencing for HIV Drug Resistance Testing in the Age of Integrase Inhibitors.
    Dalmat RR; Makhsous N; Pepper GG; Magaret A; Jerome KR; Wald A; Greninger AL
    J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30305383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq.
    Dudley DM; Bailey AL; Mehta SH; Hughes AL; Kirk GD; Westergaard RP; O'Connor DH
    Retrovirology; 2014 Dec; 11():122. PubMed ID: 25533166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Partially Multiplexed HIV Drug Resistance (HIVDR) Assay for Monitoring HIVDR Mutations of the Protease, Reverse-Transcriptase (PRRT), and Integrase (INT).
    DeVos J; McCarthy K; Sewe V; Akinyi G; Junghae M; Opollo V; Nouhin J; Shafer R; Zeh C; Ramos A; Alexander H; Chang J
    Microbiol Spectr; 2022 Jun; 10(3):e0177621. PubMed ID: 35510849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of minority HIV-1 drug resistant variants in the United Kingdom following the verification of a deep sequencing-based HIV-1 genotyping and tropism assay.
    Silver N; Paynter M; McAllister G; Atchley M; Sayir C; Short J; Winner D; Alouani DJ; Sharkey FH; Bergefall K; Templeton K; Carrington D; Quiñones-Mateu ME
    AIDS Res Ther; 2018 Nov; 15(1):18. PubMed ID: 30409215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From Sequence Data to Patient Result: A Solution for HIV Drug Resistance Genotyping With Exatype, End to End Software for Pol-HIV-1 Sanger Based Sequence Analysis and Patient HIV Drug Resistance Result Generation.
    Kingwara L; Karanja M; Ngugi C; Kangogo G; Bera K; Kimani M; Bowen N; Abuya D; Oramisi V; Mukui I
    J Int Assoc Provid AIDS Care; 2020; 19():2325958220962687. PubMed ID: 32990139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV drug resistance testing by high-multiplex "wide" sequencing on the MiSeq instrument.
    Lapointe HR; Dong W; Lee GQ; Bangsberg DR; Martin JN; Mocello AR; Boum Y; Karakas A; Kirkby D; Poon AF; Harrigan PR; Brumme CJ
    Antimicrob Agents Chemother; 2015 Nov; 59(11):6824-33. PubMed ID: 26282425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.